Literature DB >> 14982821

Tuberculosis due to multiple strains: a concern for the patient? A concern for tuberculosis control?

Marcel A Behr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982821     DOI: 10.1164/rccm.2401001

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  21 in total

Review 1.  The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach.

Authors:  S Basu; A P Galvani
Journal:  Epidemiol Infect       Date:  2008-07-07       Impact factor: 2.451

2.  Mortality among tuberculosis patients with acquired resistance to second-line antituberculosis drugs--United States, 1993-2008.

Authors:  Julia V Ershova; Ekaterina V Kurbatova; Patrick K Moonan; J Peter Cegielski
Journal:  Clin Infect Dis       Date:  2014-05-20       Impact factor: 9.079

3.  Mixed infection with Beijing and non-Beijing strains and drug resistance pattern of Mycobacterium tuberculosis.

Authors:  Han-Yu Huang; Yau-Sheng Tsai; Jen-Jeh Lee; Man-Chin Chiang; Ying-Huei Chen; Chen-Yuan Chiang; Nien-Tsung Lin; Pei-Jane Tsai
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

4.  Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing.

Authors:  E M Streicher; I Bergval; K Dheda; E C Böttger; N C Gey van Pittius; M Bosman; G Coetzee; R M Anthony; P D van Helden; T C Victor; R M Warren
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

5.  Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi.

Authors:  Kim Mallard; Ruth McNerney; Amelia C Crampin; Rein Houben; Richard Ndlovu; Lumbani Munthali; Robin M Warren; Neil French; Judith R Glynn
Journal:  J Clin Microbiol       Date:  2010-10-20       Impact factor: 5.948

6.  Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns.

Authors:  Annelies van Rie; Thomas C Victor; Madalene Richardson; Rabia Johnson; Gian D van der Spuy; Emma J Murray; Nulda Beyers; Nico C Gey van Pittius; Paul D van Helden; Robin M Warren
Journal:  Am J Respir Crit Care Med       Date:  2005-06-09       Impact factor: 21.405

Review 7.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Tuberculosis reinfection rate as a proportion of total infection rate correlates with the logarithm of the incidence rate: a mathematical model.

Authors:  Pieter W Uys; Paul D van Helden; John W Hargrove
Journal:  J R Soc Interface       Date:  2009-01-06       Impact factor: 4.118

9.  Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study.

Authors:  Sanjay Basu; Jason R Andrews; Eric M Poolman; Neel R Gandhi; N Sarita Shah; Anthony Moll; Prashini Moodley; Alison P Galvani; Gerald H Friedland
Journal:  Lancet       Date:  2007-10-27       Impact factor: 79.321

10.  Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis.

Authors:  Francine Matthys; Leen Rigouts; Vinciane Sizaire; Natalia Vezhnina; Maryvonne Lecoq; Vera Golubeva; Françoise Portaels; Patrick Van der Stuyft; Michael Kimerling
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.